LNTH Lantheus to Buy Evergreen Theragnostics Lantheus Holdings, Inc. (NASDAQ:LNTH) announced its second acquisition this ...

Radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) had some news to report Tuesday morning, but the market ...

In a report released today, David Turkaly from JMP Securities reiterated a Buy rating on Lantheus (LNTH – Research Report), with a price target ...

In trading on Tuesday, shares of Lantheus Holdings Inc (Symbol: LNTH) crossed below their 200 day moving average of $92.96, changing hands as low as $90.75 per share. Lantheus Holdings Inc shares ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Invest with Confidence: ...

Lantheus ( ($LNTH) ) has shared an update. On January 27, 2025, Lantheus Medical Imaging, a subsidiary of Lantheus Holdings, announced an ...

Lantheus Holdings Inc. is adding to its portfolio yet again, acquiring a clinical-stage radiopharmaceutical company in a deal ...

Massachusetts-based radiopharmaceutical company Lantheus (Nasdaq: LNTH) has announced a plan to acquire clinical-stage ...

The transaction is expected to be accretive to Lantheus’ Adjusted Earnings Per Share within 12 months of close. Price Action: At last check on Tuesday, LNTH stock was down 5.56% to $92.85.

View Lantheus Holdings, Inc. (LNTH) current and estimated P/E ratio data provided by Seeking Alpha.

Lantheus Holdings, Inc. (LNTH) stock price is 91.13 and Lantheus Holdings, Inc. (LNTH) 10-day simple moving average is 94.66. Lantheus Holdings, Inc. (LNTH) stock price is 91.13 and Lantheus ...